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Abstract
Gene encoding GRA1 protein is potent DNA-vaccine candidate against toxoplasmosis. The aim of the research
was to clone the gene encoding GRA1 protein of tachyzoite Toxoplasma gondii local isolate by DNA recombinant
technology. Tachyzoite was grown in Balb/c mice in vivo. Messenger RNA was isolated from total RNA and it
was used to synthesis cDNA. Complementary DNA encoding GRA1 protein of tachyzoite Toxoplasma gondii local
isolate was amplified and cloned in a prokaryote cloning vector. The recombinant GRA1-encoding gene was then
digesting using EcoRI restriction endonuclease and sequencing. The result showed that the recombinant GRA1-
encoding gene consisted of DNA sequences encoding all signal peptide and mature peptide of GRA1 protein.
Alignment of recombinant GRA1 sequence to gene encoding GRA1  protein of Toxoplasma gondii RH isolate showed
100% homologous.
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Introduction
Toxoplasma gondii is an obligate
intracellular parasite that infects most of
warm-blooded animals and important
opportunistic pathogen in humans (Sibley et
al., 1995; Carruthers, 1999). Although
infection is usually asymptomatic in
immunocompetent individuals, it can cause
severe disease manifestations and even death
in immunocompromised patients. If
infection acquired during pregnancy it can
cause abortion and various congenital
anomalies in the child (Singh, 2003). The
prevalence of positive Toxoplasma gondii
antibody in human in Indonesia is 2-63 %
(Gandahusada, 1998).
Vaccination is the best way to prevent
serious toxoplasmosis. DNA vaccine against
Toxoplasma gondii would be valuable because
it can elicit both humoral and cellular
immune responses (Vercammen et al., 2000).
So far, the only developed vaccine is the live
vaccine, attenuated tachyzoite S48.
However, this vaccine is not widely accepted
because of its side effect, short half life and
high cost. Live vaccines also carry a risk of
accidental infection of humans and
unexpected harmful reverse mutations
(Ismael et al., 2003).
Several trial DNA vaccine against
toxoplasmosis have been conducted, mainly
with mice and various Toxoplasma gondii
antigens, such as SAG1 (Angus et al., 2000),
GRA1 (Vercammen et al., 2000; Scorza et al.,
2003), GRA7 (Vercammen et al., 2000), GRA4
(Desolme et al., 2000), ROP2 (Vercammen et
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al., 2000; Leyva et al., 2001), ROP1 (Chen et
al., 2001) dan MIC3 (Ismael et al., 2003). GRA1
can elicit potentially protective immune
responses. The GRA1 antigen is secreted by
tachyzoites and bradyzoites,  it induces
humoral and cellular immune responses in
mice and humans in  the  chronic  phase of
the  infection. DNA  vaccination  using
GRA1 gene  elicits  a typical type 1 immune
response, characterized by an IgG2a-biased
antibody response and production of IFN-γ.
Epitopes from GRA1 are processed and
presented in MHC class I molecules during
infection and that the GRA1 DNA vaccine
induces specific CTLs (Vercammen et al.,
2000; Scorza et al., 2003).
Therefore, the objective of this research
was to clone the gene encoding GRA1
protein of tachyzoite Toxoplasma gondii local
isolate by DNA recombinant technology and
to compare the gene encoding GRA1 protein
of tachyzoite Toxoplasma gondii local isolate
with RH isolate.
Materials and Methods
In vivo tachyzoites cultivation
Tachyzoites Toxoplasma gondii local
isolate were obtained from Medan’s sheep
by Dr. Wayan T. Artama. BALB/c mice were
obtained from laboratory of Biotechnology
GMU. Tachyzoites were harvested from
peritoneal fluids of BALB/c mice that had
been intraperitoneally infected with 1 x 107
tachyzoites 3 to 4 days earlier. In order  to
get enough tachyzoites (1x109) many passage
were done.
Complementary DNA synthesis
The first step of cDNA synthesis was
total RNA isolation from tachyzoites. Total
RNA was isolated using RNAgents Total
RNA Isolation System (Promega). Messenger
RNA was isolated from total RNA using
PolyATract mRNA Isolation System
(Promega), and cDNA was synthesized from
mRNA using Universal Riboclone cDNA
Synthesis System (Promega). All procedures
were essentially as described by manufacture
instructions.
Complementary DNA amplification
Complementary  DNA  were amplified
using  Pure Taq RTG-PCR and specific
primer of GRA1 protein : GF1 (5’-
CGGTTTGCTTGTGTTGTTTG-3’) and GR1
(5’-CATGGGGTACGATCACAACA-3’)
(Cybergene AB). The amplified DNA
fragment consisted of all coding sequence
(signal sequences and sequences of mature
peptide). Reaction was performed under the
following condition : initial denaturation at
94oC for 5 min and continued with 32 cycle
of denaturation at 94oC for 1 min, primer
annealing at 55oC for 1 min and extension at
72oC for 1 min. The last extension phase was
prolonged for 5 min at  72oC. Following
amplification, the PCR fragment were
purified using phenol extraction.
Cloning of PCR product
The  extracted  PCR  fragment  were
cloned  into  the  cloning  vector (pGEM-T
Easy).  The recombinant plasmids were then
used to transform  E.  coli XL1-Blue using
the heat-shock method. All cloning
procedures were essentially as described by
Sambrook et al. (1989).
Isolation and analysis of recombinant
plasmid
Transformant carrying recombinant
plasmids were isolated using alkali lysis
method as described by  Sambrook et al.
(1989). Recombinant plasmids were analysed
by digesting restriction endonuclease EcoRI
and sequencing using ABI PRISM 3130
Genetic Analyser.
Results and Discussion
In vivo tachyzoites cultivation
The result of in vivo tachyzoites
cultivation was 1.9 x 109 /ml. According to
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the previous study, this result was enough
for preparing total RNA isolation.
Complementary DNA
Concentration of total RNA was 4.392
μg/μl and ratio of the purity was 1.8.
Consentration of mRNA was 0.310 μg/μl
and the total mRNA was 6.2 mg. Messenger
RNA could be separated from total RNA
because in most mature eukaryotic mRNA
had 3’-poly(A) tail that can hybridize with
oligo(dT) probe, but the other RNA
component did not. The mRNA was only
0.56 % of total RNA (typically, 1 – 5 % of total
RNA). Preparation of mRNA was hard
enough because the characteristic of RNA
that degraded easily by extremely stable
RNases in the laboratory environment.
Consentration of  cDNA was 1.877 μg/
μl and ratio of the purity was 1.76. The
quality and quantity of cDNA synthesized
by any method is critically depend on the
integrity of the mRNA used as a template.
Most cDNA molecule produced lack a few
nucleotides corresponding to the 5’ end of
the mRNA because second-strand
replacement only proceeds from 3’-OH RNA
primers. The most 5’ nick in the mRNA
generally occur several nucleotides from the
end, and the remaining RNA oligonucleotide
may be too short to remain hybridized. The
3’ to 5’ exonuclease activity of DNA
polymerase I remove the last few nucleotides
of the cDNA fisrt strand. Because all
eukaryotic mRNA have 5’ noncoding leader
sequences, which commonly range from 40
– 60 nucleotides, it is likely that the majority
of double-stranded cDNA contain all coding
sequences present in the initial cellular
mRNA.
Amplification of GRA1 cDNA
Figure 1 showed the amplification
fragment. Electrophoresis analysis of PCR
product showed that a single band was
obtained. The size of the amplified DNA
fragment is 692 bp (line 2). Spesific primer
of GRA1 gene amplified cDNA of local
isolate up to 692 bp (nucleutides position 527
to 1218) (according to the genbank, 692 bp).
This fragment consisted of signal sequences
(nucleutides position 613 - 684) and
sequences of mature peptide (nucleutides
position 685 – 1182).
Figure 1. Amplicon of cDNA using spesific primer
GF1 dan GR1 on 1% agarose gel. M: DNA marker, 1.
positive control (DNA of RH isolate), 2. cDNA of local
isolate, 3. negative control (no template).
Cloning of PCR product
The amplified  fragment was then cloned
into  pGEM-T Easy  and resulted in a
recombinant plasmid designated as pWTA-
cG1. The recombinant plasmid was
subsequently used for transformation into E.
coli XL1-Blue using the heat-shock method.
The result of transformation plasmid into E.
coli XL1-Blue demonstrated  two  kinds of
colony, blue and white colony. Blue colony
was  the result  of  hydrolysis  of
chromogenic  substrate  (X-gal)  by active β-
galactosidase. Activation of the enzyme
because of β-complementation between
amino-terminal of β-galactosidase from Lac
Z gene of vector and carboxy-terminal of  β-
galactosidase from the host cell. White
colony represented that there was DNA
fragment inserted in the cloning site, which
can cause the failure of Lac Z gene
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expression, therefore there was no α-
complementation. Therefore, the white
colony was suggested as recombinant
colony.
Analysis of recombinant plasmid
Figure 2 showed the result of restriction
analysis of the recombinant plasmid using
EcoRI.  It  was  clearly  demonstrated that
recombinant plasmid was digested into 2
fragment, 3015 bp and 692 bp (line 4). The
vector (pGEM-T Easy) from the blue colony
which had no foreign DNA insert was also
digested into single fragment, 3015 bp (line
2).
Sequensing of recombinant plasmid was
performed by using T7 and SP6 from the
construct of  pGEM-T Easy. Sequensing
using T7 resulted 1101 bp and SP6 resulted
1080 bp. So, the sequencing using both T7
and SP6 resulted the whole 692 bp of
sequence insert from both two directions.
Figure 2. Restriction analysis of recombinant plasmid
carrying DNA insert. M. DNA marker, 1. plasmid of
blue colony, 2. (1) digested with EcoRI, 3. pWTA-cG1,
4. pWTA-cG1 digested with EcoRI.
Analysis using BLAST showed that the
significant alignment was gene encoding P24
major protein (GRA1 protein) of  Toxoplasma
gondii RH isolate. Alignment recombinant
plasmid sequences showed 100 %
homologous with 526 to 1218 gene encoding
GRA1 protein of Toxoplasma gondii RH
isolate. These sequences consisted of the
whole coding sequence of GRA1 protein, it
confirmed that GRA1 protein of  Toxoplasma
gondii local isolate is not different with RH
isolate.
In conclusion, we have successfully
established a clone that carry 692 bp of the
gene encoding GRA1 protein of Toxoplasma
gondii local isolate by cDNA cloning.
Sequences of local isolate showed 100%
homologous with the gene encoding GRA1
protein of Toxoplasma gondii RH isolate.
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